萊美藥業(300006.SZ)擬接受中恆集團提供的8000萬元財務資助
格隆匯12月31日丨萊美藥業(300006.SZ)公佈,公司及公司實際控制人邱宇於2019年11月25日與廣西梧州中恆集團股份有限公司(“中恆集團”)簽訂了《戰略合作框架協議》。根據《戰略合作框架協議》約定,中恆集團將通過向公司引入優質金融資源,進一步優化公司的授信及融資條件,確保公司現金流穩定,支持公司持續穩健發展。
2019年12月30日,中恆集團第八屆董事會第二十九次會議審議通過了《中恆集團關於對重慶萊美藥業股份有限公司提供借款的議案》,中恆集團擬以自有資金向公司提供8000萬元人民幣的財務資助,用於補充公司的流動資金。
為促進公司業務發展,補充公司運營資金等需求,公司擬接受此次中恆集團向公司提供的財務資助,預計資助金額8000萬元人民幣,該資金使用期限為不超過12個月,起始日以資金實際發放日為準,財務資助利率為使用資金金額的5.5%/年。公司以全資子公司湖南康源製藥有限公司的100%股權為此次借款提供質押擔保,同時公司全資子公司重慶萊美隆宇藥業有限公司為本次借款提供連帶保證擔保。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.